Robert C Young - Net Worth and Insider Trading

Robert C Young Net Worth

The estimated net worth of Robert C Young is at least $15 Million dollars as of 2024-04-24. Robert C Young is the Director of West Pharmaceutical Services Inc and owns about 37,182 shares of West Pharmaceutical Services Inc (WST) stock worth over $15 Million. Robert C Young is also the Director of AVEO Pharmaceuticals Inc and owns about 1,000 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $15,000. Details can be seen in Robert C Young's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert C Young has not made any transactions after 2013-02-19 and currently still holds the listed stock(s).

Transaction Summary of Robert C Young

To

Robert C Young Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert C Young owns 2 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , and West Pharmaceutical Services Inc (WST) .

Click here to see the complete history of Robert C Young’s form 4 insider trades.

Insider Ownership Summary of Robert C Young

Ticker Comapny Transaction Date Type of Owner
AVEO AVEO Pharmaceuticals Inc 2016-05-26 director
WST West Pharmaceutical Services Inc 2011-08-30 director

Robert C Young Latest Holdings Summary

Robert C Young currently owns a total of 2 stocks. Among these stocks, Robert C Young owns 37,182 shares of West Pharmaceutical Services Inc (WST) as of August 30, 2011, with a value of $15 Million and a weighting of 99.9%. Robert C Young also owns 1,000 shares of AVEO Pharmaceuticals Inc (AVEO) as of February 19, 2013, with a value of $15,000 and a weighting of 0.1%.

Latest Holdings of Robert C Young

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WST West Pharmaceutical Services Inc 2011-08-30 37,182 390.20 14,508,416
AVEO AVEO Pharmaceuticals Inc 2013-02-19 1,000 15.00 15,000

Holding Weightings of Robert C Young


Robert C Young Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert C Young has made a total of 0 transactions in West Pharmaceutical Services Inc (WST) over the past 5 years. The most-recent trade in West Pharmaceutical Services Inc is the sale of 4,708 shares on August 30, 2011, which brought Robert C Young around $94,231.

According to the SEC Form 4 filings, Robert C Young has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 99 shares on February 19, 2013, which cost Robert C Young around $6,534.

Insider Trading History of Robert C Young

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert C Young Trading Performance

GuruFocus tracks the stock performance after each of Robert C Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert C Young is -15.1%. GuruFocus also compares Robert C Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert C Young within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert C Young's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert C Young

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.36 -15.1 -48.73 -71.97 -64.08 -45
Relative Return to S&P 500(%) 21.62 -21.2 -60.59 -95.21 -82.71 -56.87

Robert C Young Ownership Network

Ownership Network List of Robert C Young

No Data

Ownership Network Relation of Robert C Young


Robert C Young Owned Company Details

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Robert C Young is the director of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

Robert C Young Mailing Address

Above is the net worth, insider trading, and ownership report for Robert C Young. Currently GuruFocus does not have mailing address information for Robert C Young.

Discussions on Robert C Young

No discussions yet.